Drugs for Non-alcoholic Steatohepatitis (NASH): Quest for the Holy Grail

Nonalcoholic fatty liver disease (NAFLD) is a global epidemic that is likely to become the most common cause of chronic liver disease in the next decade, worldwide. Though numerous drugs have been evaluated in clinical trials, most of them have returned inconclusive results and shown poorly-tolerate...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of clinical and translational hepatology 2021-02, Vol.9 (1), p.40-50
Hauptverfasser:	Sharma, Mithun, Premkumar, Madhumita, Kulkarni, Anand V, Kumar, Pramod, Reddy, D Nageshwar, Rao, Nagaraja Padaki
Format:	Artikel
Sprache:	eng
Schlagworte:	Review
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!